Guineensine, a compound from black pepper, inhibited the cellular uptake of endocannabinoids at nanomolar concentrations and produced cannabis-like effects in mice that were blocked by a CB1 antagonist.
Read this if you want to learn about non-cannabis compounds that interact with the endocannabinoid system.
EC50 of 290 nanomolar for anandamide uptake inhibition from a black pepper compound
What the researchers found
Researchers identified guineensine from Piper nigrum (black pepper) as a potent inhibitor of anandamide (AEA) cellular uptake, with an EC50 of 290 nanomolar. Guineensine also inhibited 2-AG uptake. Importantly, it did not directly interact with cannabinoid receptors, FAAH, MAGL, or the fatty acid binding protein FABP5, meaning it works through a distinct mechanism from known endocannabinoid modulators.
In mice, guineensine produced the classic tetrad of cannabinoid effects: catalepsy (immobility), hypothermia (reduced body temperature), reduced locomotion, and analgesia (pain reduction). The catalepsy and analgesia were blocked by the CB1 receptor antagonist rimonabant, confirming these effects were mediated through the endocannabinoid system.
Structure-activity analysis showed that the length of the carbon chain connecting the two functional groups of guineensine was important for its activity.
Why it matters
Guineensine represents a new class of endocannabinoid modulator with a mechanism distinct from FAAH or MAGL inhibition. Its identification in black pepper adds to the list of dietary compounds that interact with the endocannabinoid system and could serve as a scaffold for developing new drugs that enhance endocannabinoid tone without directly activating cannabinoid receptors.
The numbers in context
EC50 for AEA uptake inhibition: 290 nM. Guineensine did not inhibit FAAH, MAGL, or serine hydrolases. Did not bind CB1, CB2, or FABP5. Produced catalepsy, hypothermia, reduced locomotion, and analgesia in mice.
How the study worked
High-content screening identified guineensine from black pepper. Its effects on endocannabinoid uptake were tested in cell lines. Activity-based protein profiling confirmed it did not inhibit serine hydrolases. In vivo effects were assessed in BALB/c mice using the cannabinoid tetrad (catalepsy, body temperature, locomotion, tail-flick analgesia). The CB1 antagonist rimonabant was used to confirm endocannabinoid system involvement.
What this study cannot tell us
This was a preclinical study using cell lines and mice. The concentrations of guineensine achievable through dietary black pepper consumption are likely far below those needed for pharmacological effects. The molecular target through which guineensine blocks endocannabinoid uptake was not identified.
How to read the evidence
This is a preclinical study combining in vitro screening with in vivo mouse experiments. Findings are far from clinical application.
When this study was published
Published in 2014. Research on endocannabinoid uptake mechanisms and dietary modulators has continued.
The bigger picture
The discovery of dietary compounds that modulate the endocannabinoid system opens new avenues for both drug development and understanding how food compounds affect neurochemistry. Guineensine's unique mechanism of action (blocking cellular uptake without affecting degradation enzymes) may help identify previously unknown proteins involved in endocannabinoid transport.
Questions still open
- What is the molecular target that mediates endocannabinoid cellular uptake? Could guineensine-based compounds be developed as therapeutic agents? Does dietary black pepper consumption meaningfully affect endocannabinoid tone in humans?
Common questions
Does eating black pepper get you high?
How does guineensine differ from other endocannabinoid-enhancing drugs?
Read the original research
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Pharmacological research, 80, 52-65
Citation
Nicolussi, Simon; Viveros-Paredes, Juan Manuel; Gachet, María Salomé; Rau, Mark; Flores-Soto, Mario Eduardo; Blunder, Martina; Gertsch, Jürg. (2014). Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.. Pharmacological research, 80, 52-65. https://doi.org/10.1016/j.phrs.2013.12.010
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)